Vicarious Surgical Inc (RBOT)
0.3889
+0.06
(+17.81%)
USD |
NYSE |
May 20, 15:02
Vicarious Surgical Cash from Investing (TTM): -2.099M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.099M |
| December 31, 2023 | -45.78M |
| September 30, 2023 | -51.82M |
| June 30, 2023 | -51.96M |
| March 31, 2023 | -47.16M |
| Date | Value |
|---|---|
| December 31, 2022 | -5.352M |
| September 30, 2022 | -5.227M |
| June 30, 2022 | -4.527M |
| March 31, 2022 | -3.183M |
| December 31, 2021 | -1.289M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-51.96M
Minimum
Jun 2023
-1.289M
Maximum
Dec 2021
-21.84M
Average
-5.290M
Median
Cash from Investing (TTM) Benchmarks
| Ekso Bionics Holdings Inc | -0.123M |
| Perspective Therapeutics Inc | -48.19M |
| Xtant Medical Holdings Inc | -8.037M |
| Asensus Surgical Inc | 37.77M |
| Catheter Precision Inc | -0.061M |